 Kendall Hunter
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 32 | 2022 | 1032 | 3.980 |
Why?
| | Hypertension, Pulmonary | 37 | 2023 | 1744 | 3.460 |
Why?
| | Ventricular Dysfunction, Right | 14 | 2023 | 222 | 3.340 |
Why?
| | Ventricular Function, Right | 19 | 2023 | 254 | 2.960 |
Why?
| | Heart Ventricles | 21 | 2023 | 720 | 2.850 |
Why?
| | Vascular Stiffness | 25 | 2023 | 414 | 2.550 |
Why?
| | Models, Cardiovascular | 13 | 2020 | 180 | 1.820 |
Why?
| | Pulmonary Circulation | 13 | 2022 | 409 | 1.520 |
Why?
| | Stroke Volume | 15 | 2023 | 512 | 1.400 |
Why?
| | Magnetic Resonance Imaging, Cine | 12 | 2023 | 183 | 1.290 |
Why?
| | Blood Pressure | 12 | 2021 | 1540 | 1.180 |
Why?
| | Arterial Pressure | 5 | 2019 | 100 | 1.030 |
Why?
| | Hemodynamics | 16 | 2023 | 1024 | 1.030 |
Why?
| | Vascular Resistance | 11 | 2022 | 338 | 1.010 |
Why?
| | Echocardiography, Three-Dimensional | 2 | 2023 | 48 | 0.990 |
Why?
| | Cardiac Catheterization | 13 | 2021 | 538 | 0.960 |
Why?
| | Fontan Procedure | 6 | 2023 | 160 | 0.950 |
Why?
| | Echocardiography | 9 | 2023 | 563 | 0.920 |
Why?
| | Imaging, Three-Dimensional | 4 | 2013 | 538 | 0.870 |
Why?
| | Phantoms, Imaging | 2 | 2014 | 137 | 0.840 |
Why?
| | Magnetic Resonance Imaging | 12 | 2023 | 3128 | 0.810 |
Why?
| | Magnetic Resonance Angiography | 4 | 2019 | 240 | 0.800 |
Why?
| | Blood Flow Velocity | 8 | 2019 | 395 | 0.770 |
Why?
| | Forecasting | 1 | 2021 | 333 | 0.680 |
Why?
| | Carotid Arteries | 3 | 2018 | 183 | 0.620 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 64 | 0.590 |
Why?
| | Computer Simulation | 9 | 2019 | 879 | 0.570 |
Why?
| | Aorta, Thoracic | 6 | 2023 | 261 | 0.530 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 5 | 0.520 |
Why?
| | Collagen | 6 | 2014 | 416 | 0.510 |
Why?
| | Heart Defects, Congenital | 4 | 2023 | 666 | 0.500 |
Why?
| | Child | 33 | 2023 | 18468 | 0.490 |
Why?
| | Elastic Modulus | 4 | 2013 | 116 | 0.480 |
Why?
| | Aorta | 6 | 2020 | 394 | 0.470 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 466 | 0.450 |
Why?
| | Male | 49 | 2023 | 55814 | 0.450 |
Why?
| | Portal Vein | 1 | 2014 | 82 | 0.430 |
Why?
| | Heart-Assist Devices | 4 | 2021 | 485 | 0.430 |
Why?
| | Cattle | 10 | 2023 | 925 | 0.420 |
Why?
| | Industry | 1 | 2013 | 65 | 0.420 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 42 | 0.410 |
Why?
| | Tetralogy of Fallot | 1 | 2012 | 87 | 0.390 |
Why?
| | Adolescent | 25 | 2023 | 17889 | 0.390 |
Why?
| | Humans | 64 | 2023 | 115222 | 0.390 |
Why?
| | Placental Insufficiency | 1 | 2013 | 102 | 0.390 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 291 | 0.380 |
Why?
| | Female | 44 | 2023 | 59720 | 0.370 |
Why?
| | Extracellular Matrix | 5 | 2021 | 436 | 0.360 |
Why?
| | Blood Pressure Determination | 2 | 2008 | 122 | 0.360 |
Why?
| | Pulse Wave Analysis | 6 | 2023 | 210 | 0.350 |
Why?
| | Myocardial Contraction | 4 | 2020 | 314 | 0.350 |
Why?
| | Heart Failure | 5 | 2023 | 1962 | 0.350 |
Why?
| | Elasticity | 6 | 2015 | 190 | 0.350 |
Why?
| | Predictive Value of Tests | 9 | 2023 | 1816 | 0.350 |
Why?
| | Ventricular Function, Left | 5 | 2023 | 474 | 0.350 |
Why?
| | Ultrasonography | 1 | 2013 | 641 | 0.340 |
Why?
| | Retrospective Studies | 18 | 2023 | 12597 | 0.320 |
Why?
| | Stress, Physiological | 1 | 2012 | 377 | 0.320 |
Why?
| | Fetus | 1 | 2013 | 702 | 0.320 |
Why?
| | Hypoxia | 4 | 2023 | 959 | 0.310 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2021 | 699 | 0.310 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2020 | 114 | 0.310 |
Why?
| | Aortic Diseases | 2 | 2021 | 110 | 0.310 |
Why?
| | Infant | 12 | 2021 | 7966 | 0.310 |
Why?
| | Stress, Mechanical | 9 | 2019 | 449 | 0.300 |
Why?
| | Image Interpretation, Computer-Assisted | 4 | 2018 | 243 | 0.300 |
Why?
| | Case-Control Studies | 13 | 2019 | 3023 | 0.290 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 929 | 0.290 |
Why?
| | Elastin | 6 | 2015 | 78 | 0.280 |
Why?
| | Cardiac Output | 4 | 2020 | 144 | 0.280 |
Why?
| | Heart Septal Defects | 1 | 2006 | 10 | 0.280 |
Why?
| | Vasomotor System | 1 | 2006 | 39 | 0.270 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2019 | 366 | 0.270 |
Why?
| | Child, Preschool | 14 | 2023 | 9124 | 0.270 |
Why?
| | Follow-Up Studies | 5 | 2021 | 4430 | 0.250 |
Why?
| | Regional Blood Flow | 4 | 2021 | 432 | 0.250 |
Why?
| | Reproducibility of Results | 7 | 2018 | 2806 | 0.250 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2344 | 0.240 |
Why?
| | Heart Transplantation | 2 | 2023 | 671 | 0.240 |
Why?
| | Arteries | 2 | 2018 | 249 | 0.230 |
Why?
| | Models, Biological | 1 | 2011 | 1638 | 0.230 |
Why?
| | Animals | 21 | 2023 | 31884 | 0.230 |
Why?
| | Myocardium | 3 | 2023 | 925 | 0.220 |
Why?
| | Patient-Specific Modeling | 3 | 2020 | 37 | 0.220 |
Why?
| | Prospective Studies | 9 | 2021 | 6245 | 0.220 |
Why?
| | Electrocardiography | 2 | 2023 | 563 | 0.210 |
Why?
| | Materials Testing | 2 | 2017 | 345 | 0.210 |
Why?
| | Endothelial Cells | 3 | 2023 | 686 | 0.210 |
Why?
| | Severity of Illness Index | 6 | 2019 | 2552 | 0.210 |
Why?
| | Umbilical Arteries | 2 | 2013 | 41 | 0.210 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1717 | 0.200 |
Why?
| | Perfusion Imaging | 2 | 2019 | 55 | 0.200 |
Why?
| | Assisted Circulation | 1 | 2021 | 25 | 0.190 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 279 | 0.190 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 1731 | 0.180 |
Why?
| | Glycopeptides | 1 | 2021 | 43 | 0.180 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 97 | 0.180 |
Why?
| | Disease Models, Animal | 7 | 2023 | 3547 | 0.180 |
Why?
| | Ventricular Pressure | 1 | 2019 | 37 | 0.170 |
Why?
| | Peptide Fragments | 2 | 2021 | 668 | 0.170 |
Why?
| | Age Factors | 5 | 2019 | 2900 | 0.160 |
Why?
| | Lung | 5 | 2015 | 3595 | 0.160 |
Why?
| | Sheep | 4 | 2014 | 764 | 0.160 |
Why?
| | Prognosis | 5 | 2019 | 3336 | 0.160 |
Why?
| | Marfan Syndrome | 1 | 2018 | 43 | 0.160 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 30 | 0.150 |
Why?
| | Turner Syndrome | 1 | 2018 | 45 | 0.150 |
Why?
| | Microcirculation | 2 | 2016 | 136 | 0.150 |
Why?
| | Cardiorespiratory Fitness | 1 | 2018 | 36 | 0.150 |
Why?
| | Models, Theoretical | 2 | 2013 | 517 | 0.150 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.150 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 71 | 0.150 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 93 | 0.150 |
Why?
| | ROC Curve | 2 | 2015 | 447 | 0.140 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 76 | 0.140 |
Why?
| | Aortic Coarctation | 1 | 2018 | 71 | 0.140 |
Why?
| | Algorithms | 4 | 2019 | 1488 | 0.140 |
Why?
| | Shear Strength | 3 | 2018 | 65 | 0.140 |
Why?
| | Hemorheology | 1 | 2016 | 21 | 0.130 |
Why?
| | Pressure | 2 | 2019 | 219 | 0.130 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 481 | 0.130 |
Why?
| | Glycocalyx | 1 | 2016 | 19 | 0.130 |
Why?
| | Arterioles | 1 | 2016 | 40 | 0.130 |
Why?
| | Physical Conditioning, Animal | 1 | 2018 | 196 | 0.130 |
Why?
| | Biomimetic Materials | 1 | 2017 | 64 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 827 | 0.130 |
Why?
| | Capillaries | 1 | 2016 | 92 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2022 | 3250 | 0.130 |
Why?
| | Young Adult | 8 | 2021 | 10520 | 0.130 |
Why?
| | Principal Component Analysis | 3 | 2023 | 177 | 0.130 |
Why?
| | Software | 2 | 2023 | 538 | 0.130 |
Why?
| | Compliance | 2 | 2012 | 46 | 0.120 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2021 | 191 | 0.120 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 236 | 0.120 |
Why?
| | Area Under Curve | 1 | 2015 | 275 | 0.120 |
Why?
| | Animals, Newborn | 3 | 2015 | 779 | 0.120 |
Why?
| | Oxygen Consumption | 1 | 2017 | 590 | 0.120 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2023 | 138 | 0.120 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 179 | 0.120 |
Why?
| | Endotoxins | 1 | 2015 | 205 | 0.120 |
Why?
| | Pulsatile Flow | 1 | 2014 | 54 | 0.120 |
Why?
| | Adventitia | 1 | 2014 | 37 | 0.120 |
Why?
| | Bronchi | 1 | 2015 | 243 | 0.120 |
Why?
| | Contrast Media | 1 | 2017 | 369 | 0.120 |
Why?
| | Image Enhancement | 1 | 2015 | 181 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 417 | 0.120 |
Why?
| | Time Factors | 4 | 2021 | 6157 | 0.120 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 6 | 0.110 |
Why?
| | Middle Aged | 9 | 2021 | 26873 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 39 | 0.110 |
Why?
| | Precision Medicine | 1 | 2017 | 340 | 0.110 |
Why?
| | Toll-Like Receptor 2 | 1 | 2014 | 109 | 0.110 |
Why?
| | Oscillometry | 1 | 2013 | 33 | 0.110 |
Why?
| | Pilot Projects | 3 | 2021 | 1377 | 0.110 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2014 | 132 | 0.110 |
Why?
| | Polymers | 1 | 2017 | 448 | 0.110 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 515 | 0.110 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 33 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2015 | 744 | 0.100 |
Why?
| | Vitamin D | 1 | 2015 | 340 | 0.100 |
Why?
| | Equipment Design | 1 | 2014 | 513 | 0.100 |
Why?
| | Models, Statistical | 1 | 2015 | 603 | 0.100 |
Why?
| | Reference Values | 2 | 2017 | 748 | 0.100 |
Why?
| | Pregnancy | 5 | 2015 | 5525 | 0.100 |
Why?
| | Elastic Tissue | 1 | 2011 | 8 | 0.100 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 12 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 3422 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 604 | 0.090 |
Why?
| | Linear Models | 2 | 2018 | 779 | 0.090 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 165 | 0.090 |
Why?
| | NF-kappa B | 1 | 2014 | 637 | 0.090 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 6 | 0.090 |
Why?
| | Exercise | 1 | 2020 | 1644 | 0.090 |
Why?
| | Biomechanical Phenomena | 4 | 2017 | 676 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2098 | 0.090 |
Why?
| | Uncertainty | 1 | 2010 | 95 | 0.080 |
Why?
| | Vasodilator Agents | 1 | 2011 | 307 | 0.080 |
Why?
| | Ultrasonics | 1 | 2009 | 47 | 0.080 |
Why?
| | Ventricular Remodeling | 2 | 2023 | 227 | 0.080 |
Why?
| | Microbubbles | 1 | 2009 | 40 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2020 | 2158 | 0.080 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 142 | 0.080 |
Why?
| | Fibrosis | 2 | 2021 | 455 | 0.080 |
Why?
| | Mechanotransduction, Cellular | 2 | 2023 | 97 | 0.080 |
Why?
| | Risk Factors | 3 | 2017 | 8658 | 0.080 |
Why?
| | Logistic Models | 2 | 2015 | 1841 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 160 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 106 | 0.070 |
Why?
| | Electric Impedance | 1 | 2007 | 98 | 0.070 |
Why?
| | Probability | 1 | 2007 | 290 | 0.070 |
Why?
| | Hypertension | 2 | 2012 | 1060 | 0.060 |
Why?
| | Disease Progression | 3 | 2018 | 2390 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2018 | 9151 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1594 | 0.060 |
Why?
| | Protein-Losing Enteropathies | 1 | 2023 | 11 | 0.060 |
Why?
| | Vasodilation | 2 | 2018 | 417 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2019 | 4419 | 0.050 |
Why?
| | Rats | 3 | 2018 | 4980 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 27 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 79 | 0.050 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.050 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 10 | 0.050 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 15 | 0.050 |
Why?
| | Heart Murmurs | 1 | 2021 | 11 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2022 | 442 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2021 | 154 | 0.040 |
Why?
| | Coronary Circulation | 1 | 2020 | 135 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 12 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 475 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 387 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 641 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 2216 | 0.040 |
Why?
| | Pediatrics | 1 | 2006 | 986 | 0.040 |
Why?
| | Rabbits | 1 | 2019 | 750 | 0.040 |
Why?
| | Diastole | 1 | 2018 | 133 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 130 | 0.040 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 20 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 74 | 0.040 |
Why?
| | Exercise Test | 1 | 2020 | 545 | 0.040 |
Why?
| | Hyperplasia | 1 | 2018 | 165 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 71 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 293 | 0.040 |
Why?
| | Rare Diseases | 1 | 2018 | 89 | 0.040 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 102 | 0.040 |
Why?
| | Aftercare | 1 | 2019 | 186 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2020 | 351 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1635 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2018 | 369 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 844 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 387 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 58 | 0.040 |
Why?
| | Vasoconstriction | 1 | 2018 | 186 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 94 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2018 | 214 | 0.030 |
Why?
| | Heart Valve Diseases | 1 | 2018 | 159 | 0.030 |
Why?
| | Education | 1 | 2017 | 95 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 268 | 0.030 |
Why?
| | Blood Viscosity | 1 | 2016 | 17 | 0.030 |
Why?
| | Heart | 1 | 2020 | 613 | 0.030 |
Why?
| | Aged | 3 | 2019 | 19136 | 0.030 |
Why?
| | Capillary Permeability | 1 | 2016 | 136 | 0.030 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 29 | 0.030 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2016 | 71 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 222 | 0.030 |
Why?
| | Risk | 1 | 2018 | 816 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2017 | 237 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1231 | 0.030 |
Why?
| | Demography | 1 | 2015 | 261 | 0.030 |
Why?
| | Aortic Valve | 1 | 2018 | 397 | 0.030 |
Why?
| | Hematocrit | 1 | 2014 | 85 | 0.030 |
Why?
| | Tricuspid Valve | 1 | 2014 | 25 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 214 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 133 | 0.030 |
Why?
| | Cardiomyopathies | 1 | 2017 | 301 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 299 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2014 | 5052 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1650 | 0.030 |
Why?
| | Altitude Sickness | 1 | 2014 | 172 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 541 | 0.030 |
Why?
| | Mice | 2 | 2021 | 14934 | 0.030 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 286 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 592 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 812 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 2525 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 477 | 0.020 |
Why?
| | Species Specificity | 1 | 2011 | 549 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 758 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3897 | 0.020 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 36 | 0.020 |
Why?
| | Tunica Media | 1 | 2007 | 35 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 503 | 0.020 |
Why?
| | Finite Element Analysis | 1 | 2007 | 66 | 0.020 |
Why?
| | Tunica Intima | 1 | 2007 | 78 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2192 | 0.020 |
Why?
| | Protein Conformation | 1 | 2008 | 811 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 4718 | 0.020 |
Why?
| | Colorado | 1 | 2014 | 4099 | 0.010 |
Why?
| | Radiography | 1 | 2007 | 827 | 0.010 |
Why?
| | Research Design | 1 | 2010 | 933 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2485 | 0.010 |
Why?
| | Adult | 2 | 2017 | 30711 | 0.010 |
Why?
| | United States | 1 | 2017 | 12256 | 0.010 |
Why?
|
|
Hunter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|